Former Owner of Telemedicine Companies Sentenced for $110 Million Medicare Fraud Scheme

What this means for your practice

This enforcement action serves as a stark reminder for all healthcare businesses, especially those operating in the telehealth space, of the severe consequences associated with Medicare and telemedicine fraud. The DOJ's explicit identification of telemedicine fraud, alongside other areas like kickbacks and controlled-substance diversion, signals continued scrutiny and aggressive prosecution in these sectors. Practices providing or referring durable medical equipment (DME), orthotics, or engaging in any form of Medicare/Medicaid billing must ensure their operations are meticulously compliant. Thorough documentation of medical necessity, adherence to anti-kickback statutes, and robust compliance programs are paramount. This sentencing underscores the necessity for proactive compliance measures to mitigate legal and financial risks, particularly as telehealth continues to expand.

DOJ Reinforces Focus on Telemedicine and Healthcare Fraud Enforcement

The Department of Justice (DOJ) has recently reiterated its critical healthcare enforcement priorities, signaling a persistent focus on combating various forms of fraud within the medical sector. Among the key areas explicitly identified by the DOJ are telemedicine fraud, Medicare/Medicaid fraud, illegal kickbacks, diversion of controlled substances, home health and hospice scams, and deceptive marketing practices. This clear articulation of enforcement priorities provides significant insight into the government's strategic focus for protecting federal healthcare programs and ensuring patient safety.

Telemedicine Fraud Leads to Significant Sentencing in Boston

In a concrete demonstration of these enforcement priorities, the former owner of two telemedicine companies, Expansion Media (Expansion) and Hybrid Management Group (Hybrid), has been sentenced in federal court in Boston. The sentencing pertains to a substantial $110 million Medicare fraud scheme that involved the provision of medically unnecessary durable medical equipment (DME), specifically including orthotics such such as back and knee braces.

The Office of Inspector General (OIG) of the U.S. Department of Health and Human Services highlighted this case as part of its ongoing government oversight efforts. The enforcement action, led by the U.S. Attorney's Office for the District of Massachusetts, involved both criminal and civil actions, underscoring the comprehensive approach taken by federal authorities against healthcare fraud.

Details of the Fraud Scheme and Enforcement Action

The scheme centered around exploiting the Medicare system through the submission of claims for DME that lacked medical necessity. The involvement of telemedicine companies in facilitating this fraud highlights the vulnerabilities and risks associated with remote healthcare services when not conducted within stringent regulatory guidelines. The large sum of $110 million associated with the fraudulent claims signifies the extensive scale and impact of such illicit activities on taxpayer-funded programs.

The action details provided by the OIG indicate an action date of August 20, 2026, which aligns with the U.S. Attorney's Office, District of Massachusetts's jurisdiction over the matter. The sentencing of the former owner sends a strong message regarding the federal government's commitment to holding individuals accountable for orchestrating and profiting from healthcare fraud schemes.

Broader Implications for Healthcare Providers

This case is a salient example of how the DOJ’s stated priorities translate into tangible enforcement outcomes. The focus on telemedicine fraud is particularly relevant as the use of telehealth services continues to expand across the United States. Providers engaging in telehealth, whether for general medical consultations, specialty care, or the referral of DME, must operate with an unwavering commitment to compliance.

The emphasis on medically unnecessary services underscores the importance of thorough clinical documentation and legitimate patient encounters as the foundation of all healthcare billing. Any practice involved in the provision or referral of DME, particularly orthotics, should review its internal processes to ensure that all items are provided based on documented medical necessity and in compliance with all federal and state regulations. The combination of criminal and civil actions in this case also demonstrates the multi-faceted legal risks involved, encompassing potential imprisonment, significant financial penalties, and exclusion from federal healthcare programs.

Vigilance and Compliance: A Continuous Requirement

The enduring focus of the OIG and DOJ on uncovering and prosecuting sophisticated healthcare fraud schemes, especially those leveraging evolving healthcare delivery models like telemedicine, necessitates a culture of rigorous compliance within all healthcare organizations. From small dental practices considering telehealth consultations to large medspas offering remote services or chiropractic offices referring orthotics, the principles of legitimate patient care, accurate billing, and strict adherence to anti-kickback provisions remain paramount. The Boston sentencing reinforces that regulatory scrutiny extends to all facets of the healthcare ecosystem, demanding continuous vigilance and proactive measures to prevent fraud and abuse.

Key Facts

| Detail | Value | |---|---| | Defendant's Role | Former owner of Expansion Media and Hybrid Management Group | | Fraud Amount | $110 million | | Fraud Type | Telemedicine fraud scheme involving medically unnecessary durable medical equipment (DME), specifically orthotics such as back and knee braces | | Location of Sentencing | Federal court in Boston | | Enforcing Agency (Action) | U.S. Attorney's Office, District of Massachusetts | | Enforcement Types | Criminal and Civil Actions | | Action Details Date | Aug. 20, 2026, midnight |

Frequently Asked Questions

What specific types of fraud are highlighted by the DOJ as enforcement priorities?

The Department of Justice explicitly identified telemedicine fraud, Medicare/Medicaid fraud, kickbacks, controlled-substance diversion, home health/hospice scams, and deceptive marketing as current healthcare enforcement priorities.

What was the nature of the $110 million fraud scheme discussed in the OIG announcement?

The scheme involved a former owner of telemedicine companies being sentenced for a $110 million Medicare fraud scheme that focused on providing medically unnecessary durable medical equipment (DME), including orthotics such as back and knee braces.

Which government agencies were involved in this enforcement action?

The U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) highlighted the case, and the U.S. Attorney's Office for the District of Massachusetts was the agency responsible for the specific criminal and civil enforcement actions.

What was the outcome for the former owner of the telemedicine companies?

The former owner of Expansion Media and Hybrid Management Group was sentenced in federal court in Boston, involving both criminal and civil actions related to the $110 million Medicare fraud scheme.

What types of businesses or services are particularly affected by these enforcement priorities?

Businesses involved in telemedicine, durable medical equipment (DME) provision, orthotics, and any services billing Medicare or Medicaid should pay close attention to these enforcement priorities.

Source: oig.hhs.gov — DOJ Outlines Key Healthcare Enforcement Priorities